Key statistics
On Friday, Applied Therapeutics Inc (2UV:BER) closed at 7.12, -7.78% below its 52-week high of 7.72, set on Sep 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.16 |
---|---|
High | 7.27 |
Low | 6.96 |
Bid | 6.81 |
Offer | 7.02 |
Previous close | 7.35 |
Average volume | 2.89k |
---|---|
Shares outstanding | 114.85m |
Free float | 108.75m |
P/E (TTM) | -- |
Market cap | 884.32m USD |
EPS (TTM) | -1.52 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 19:30 BST.
More ▼
Announcements
- Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
- Applied Therapeutics to Participate in Upcoming Investor Conferences
- Applied Therapeutics Reports Second Quarter 2024 Financial Results
- Applied Therapeutics Added to Russell 3000® Index
- Applied Therapeutics Reports First Quarter 2024 Financial Results
- Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
- Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
- Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
- Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
- Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
More ▼